MedPath

Nicergoline

Generic Name
Nicergoline
Drug Type
Small Molecule
Chemical Formula
C24H26BrN3O3
CAS Number
27848-84-6
Unique Ingredient Identifier
JCV8365FWN
Background

An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It has been suggested to ameliorate cognitive deficits in cerebrovascular disease.

Indication

For the treatment of senile dementia, migraines of vascular origin, transient ischemia, platelet hyper-aggregability, and macular degeneration.

Associated Conditions
Ischemic Stroke, Transient Ischemic Attack
Associated Therapies
Peripheral vasodilatation

Nicergoline Use in Dysphagia Patients

Phase 3
Not yet recruiting
Conditions
Dysphagia
Interventions
First Posted Date
2022-09-22
Last Posted Date
2022-12-23
Lead Sponsor
Phramongkutklao College of Medicine and Hospital
Target Recruit Count
60
Registration Number
NCT05551182
Locations
🇹🇭

Phramongkutklao Hospital, Ratchathewi, Bangkok, Thailand

An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants

Phase 1
Completed
Conditions
Pharmacokinetics
Interventions
First Posted Date
2019-11-25
Last Posted Date
2021-01-27
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Target Recruit Count
40
Registration Number
NCT04176367
Locations
🇨🇳

Beijing Hospital, Beijing, China

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Dementia
Depression
Schizophrenia
Psychosomatic Disorders
Anxiety Disorders
Interventions
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath